z-logo
open-access-imgOpen Access
Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2
Author(s) -
Jerzy Głuszek,
Teresa Kosicka
Publication year - 2022
Publication title -
arterial hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 9
eISSN - 2449-6170
pISSN - 2449-6162
DOI - 10.5603/ah.a2021.0014
Subject(s) - medicine , angiotensin converting enzyme 2 , disease , angiotensin converting enzyme , covid-19 , renin–angiotensin system , death toll , virus , angiotensin ii , angiotensin receptor blockers , enzyme , immunology , intensive care medicine , receptor , blood pressure , biology , infectious disease (medical specialty) , environmental health , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom